Dopamine and the motivation to move
This study investigates how the brain's dopamine system relates to effort and movement early in Parkinson's.
Testing a treatment or activity · Study reference: DRKS00038038
Plain-language introduction written with AI from the registry; not independently checked by a clinician. Read the original details below ↓
This registry record was last updated over six months ago, or its update date is missing. Recruitment may have changed. Confirm with the team before making plans.
Open the official registry record ↗Follow this study
Looking for volunteers
- Start (reported date)
- 2025-12-16
Planned dates can move. A study finishing does not tell us when a paper will be published.
No results summary has been confirmed in the registry records we imported. See connected papers below; we keep checking after recruitment ends.
Changes we have recorded
- 2026-10-11 — recruiting
These are dates we observed a change, not necessarily the dates it happened.
Papers connected to this study
No connected paper has been found yet. The tracker checks the growing library for study identifiers and registry-linked publications.
Who can join?
Ages 50 years to 80 years · Ask the team who can join
These are starting points, not the full rules. The research team can tell you whether the study is right for your situation.
Read all the rules for taking part
Sex eligibility reported by registry: all
Full study name & original research details
Official study title
Striatal Dopamine and Motor Control: Trait- and State-Dependent Motivation for Motor Effort - DoMoCo2
Short title used by the registry
Striatal Dopamine and Motor Control: Trait- and State-Dependent Motivation for Motor Effort
Original description
Conditions reported: Parkinson's Disease G20;Parkinson disease
Registry records for this study
Records are joined using registration identifiers. Titles alone do not establish that two studies are the same.
- German Clinical Trials Register · DRKS00038038 ↗ — Recruiting; WHO ICTRP processed 2026-02-02; checked 2026-10-14
- Study type
- Interventional
- Interventions
- Group 1: Clinical population: 36 people with less than 2 years of clinical Parkinson's Disease (PD) diagnosis according to the MDS clinical diagnostic criteria (including male and females). All study participants (patients with PD and HC) will undergo the same study protocol. The study consists out of three visits, including one neuroimaging session as well as a counter-balanced sham/stimulation phase of vagus nerve stimulation across the three visits. At all three visits motor tests and a motivational force task will be employed.Group 2: Healthy control population: 36 healthy control (HC) subjects will be selected to match the patient cohort according to age, sex, handedness and education. All study participants (patients with PD and HC) will undergo the same study protocol. The study consists out of three visits, including one neuroimaging session as well as a counter-balanced sham/stimulation phase of vagus nerve stimulation across the three visits. At all three visits motor tests and a motivational force task will be employed.
- Phases
- N/A
- Sponsor
- Uniklinik Köln, Klinik für Neurologie und Klinik für Nuklearmedizin
- Start date reported by registry
- 2025-12-16 (reported)
Registry updated: Not reported · Status last verified by the registry submitter: Not reported
Registry records retrieved 2026-10-14 (UTC). Individual records may have older updates. Recruitment and eligibility must be confirmed with the study team.
Contact the research team
Public study contacts supplied to the registry. Ask whether recruitment is still open and what participation involves.
Thilo van Eimeren · +49-221-478 82843 · thilo.van-eimeren@uk-koeln.de
Study locations
Site status can differ from overall study status. “Status not reported” means local availability needs confirmation. Remote participation and travel arrangements must be checked with the team.
Facility not reported
Germany
Status not reportedThe original descriptions and participation rules come from the registry. Participation is voluntary and does not guarantee benefit.